Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I J Sniecinski

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Immunology Series|January 1, 1989
Lymphokine-activated killer lymphocytes: extramural clinical trialsI J Sniecinski
Infusionstherapie Und Klinische Ernahrung|September 1, 1987
Safety of apheresis donationI J Sniecinski
Artificial Organs|June 1, 1988
An artificial lymph gland: a new approach to cancer therapyA A Pineda, I J Sniecinski, H C Stevenson
Transplantation Proceedings|December 1, 1987
Immunohematologic problems arising from ABO incompatible bone marrow transplantationI J Sniecinski, L D Petz, L Oien, et al.
Transplantation|March 1, 1988
Immunohematologic consequences of major ABO-mismatched bone marrow transplantationI J Sniecinski, L Oien, L D Petz, et al.
Transplantation|May 1, 1991
Persistence of bcr-able gene expression following bone marrow transplantation for chronic myelogenous leukemia in chronic phaseD S Snyder, J J Rossi, J L Wang, et al.
The Journal of Urology|September 1, 1983
Immunohistochemical demonstration of blood group antigens in neoplastic and normal human urothelium: a comparison with standard red cell adherenceR C Flanigan, C T King, T D Clark, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 1, 1986
Bone marrow transplantation for hematologic malignancies in patients aged 30 years or olderK G Blume, S J Forman, A P Nademanee, et al.
Blut|July 1, 1988
Fractionated total body irradiation and high dose cyclophosphamide: a preparative regimen for bone marrow transplantation for patients with hematologic malignancies in first complete remissionD S Snyder, D O Findley, S J Forman, et al.
Transplantation|March 1, 1987
Allogeneic bone marrow transplantation for acute lymphoblastic leukemia during first complete remissionK G Blume, S J Forman, D S Snyder, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Immunology Series|January 1, 1989
Lymphokine-activated killer lymphocytes: extramural clinical trialsI J Sniecinski
Infusionstherapie Und Klinische Ernahrung|September 1, 1987
Safety of apheresis donationI J Sniecinski
Artificial Organs|June 1, 1988
An artificial lymph gland: a new approach to cancer therapyA A Pineda, I J Sniecinski, H C Stevenson
Transplantation Proceedings|December 1, 1987
Immunohematologic problems arising from ABO incompatible bone marrow transplantationI J Sniecinski, L D Petz, L Oien, et al.
Transplantation|March 1, 1988
Immunohematologic consequences of major ABO-mismatched bone marrow transplantationI J Sniecinski, L Oien, L D Petz, et al.
Transplantation|May 1, 1991
Persistence of bcr-able gene expression following bone marrow transplantation for chronic myelogenous leukemia in chronic phaseD S Snyder, J J Rossi, J L Wang, et al.
The Journal of Urology|September 1, 1983
Immunohistochemical demonstration of blood group antigens in neoplastic and normal human urothelium: a comparison with standard red cell adherenceR C Flanigan, C T King, T D Clark, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 1, 1986
Bone marrow transplantation for hematologic malignancies in patients aged 30 years or olderK G Blume, S J Forman, A P Nademanee, et al.
Blut|July 1, 1988
Fractionated total body irradiation and high dose cyclophosphamide: a preparative regimen for bone marrow transplantation for patients with hematologic malignancies in first complete remissionD S Snyder, D O Findley, S J Forman, et al.
Transplantation|March 1, 1987
Allogeneic bone marrow transplantation for acute lymphoblastic leukemia during first complete remissionK G Blume, S J Forman, D S Snyder, et al.
Pageof 1